Application of ZnO-based nanocomposites for vaccines and cancer immunotherapy

Prashant Sharma, Na Yoon Jang, Jae Won Lee, Bum Chul Park, Young Keun Kim, Nam Hyuk Cho

Research output: Contribution to journalReview article

Abstract

Engineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective mass production. In addition, recent advances in nano-engineering technologies enable the generation of ZnO nanocomposites with unique three-dimensional structures and surface characteristics that are optimally designed for in vivo applications. Here, we review recent advances in the application of diverse ZnO nanocomposites, with an especial focus on their development as vaccine adjuvant and cancer immunotherapeutics, as well as their intrinsic properties interacting with the immune system and potential toxic effect in vivo. Finally, we summarize promising proof-of-concept applications as prophylactic and therapeutic vaccines against infections and cancers. Understanding the nano-bio interfaces between ZnO-based nanocomposites and the immune system, together with bio-effective design of the nanomaterial using nano-architectonic technology, may open new avenues in expanding the biomedical application of ZnO nanocomposites as a novel vaccine platform.

Original languageEnglish
Article number493
JournalPharmaceutics
Volume11
Issue number10
DOIs
Publication statusPublished - 2019 Oct

Fingerprint

Zinc Oxide
Nanocomposites
Cancer Vaccines
Immunotherapy
Nanostructures
Immune System
Vaccines
Technology
Poisons
Costs and Cost Analysis
Infection
Neoplasms

Keywords

  • Cancer
  • Immune cells
  • Immunotherapy
  • Toxicity
  • Vaccine
  • ZnO nanocomposite

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Application of ZnO-based nanocomposites for vaccines and cancer immunotherapy. / Sharma, Prashant; Jang, Na Yoon; Lee, Jae Won; Park, Bum Chul; Kim, Young Keun; Cho, Nam Hyuk.

In: Pharmaceutics, Vol. 11, No. 10, 493, 10.2019.

Research output: Contribution to journalReview article

Sharma, Prashant ; Jang, Na Yoon ; Lee, Jae Won ; Park, Bum Chul ; Kim, Young Keun ; Cho, Nam Hyuk. / Application of ZnO-based nanocomposites for vaccines and cancer immunotherapy. In: Pharmaceutics. 2019 ; Vol. 11, No. 10.
@article{e36ff8f85b864446b3b23c1f82886fce,
title = "Application of ZnO-based nanocomposites for vaccines and cancer immunotherapy",
abstract = "Engineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective mass production. In addition, recent advances in nano-engineering technologies enable the generation of ZnO nanocomposites with unique three-dimensional structures and surface characteristics that are optimally designed for in vivo applications. Here, we review recent advances in the application of diverse ZnO nanocomposites, with an especial focus on their development as vaccine adjuvant and cancer immunotherapeutics, as well as their intrinsic properties interacting with the immune system and potential toxic effect in vivo. Finally, we summarize promising proof-of-concept applications as prophylactic and therapeutic vaccines against infections and cancers. Understanding the nano-bio interfaces between ZnO-based nanocomposites and the immune system, together with bio-effective design of the nanomaterial using nano-architectonic technology, may open new avenues in expanding the biomedical application of ZnO nanocomposites as a novel vaccine platform.",
keywords = "Cancer, Immune cells, Immunotherapy, Toxicity, Vaccine, ZnO nanocomposite",
author = "Prashant Sharma and Jang, {Na Yoon} and Lee, {Jae Won} and Park, {Bum Chul} and Kim, {Young Keun} and Cho, {Nam Hyuk}",
year = "2019",
month = "10",
doi = "10.3390/pharmaceutics11100493",
language = "English",
volume = "11",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Application of ZnO-based nanocomposites for vaccines and cancer immunotherapy

AU - Sharma, Prashant

AU - Jang, Na Yoon

AU - Lee, Jae Won

AU - Park, Bum Chul

AU - Kim, Young Keun

AU - Cho, Nam Hyuk

PY - 2019/10

Y1 - 2019/10

N2 - Engineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective mass production. In addition, recent advances in nano-engineering technologies enable the generation of ZnO nanocomposites with unique three-dimensional structures and surface characteristics that are optimally designed for in vivo applications. Here, we review recent advances in the application of diverse ZnO nanocomposites, with an especial focus on their development as vaccine adjuvant and cancer immunotherapeutics, as well as their intrinsic properties interacting with the immune system and potential toxic effect in vivo. Finally, we summarize promising proof-of-concept applications as prophylactic and therapeutic vaccines against infections and cancers. Understanding the nano-bio interfaces between ZnO-based nanocomposites and the immune system, together with bio-effective design of the nanomaterial using nano-architectonic technology, may open new avenues in expanding the biomedical application of ZnO nanocomposites as a novel vaccine platform.

AB - Engineering and application of nanomaterials have recently helped advance various biomedical fields. Zinc oxide (ZnO)-based nanocomposites have become one of the most promising candidates for biomedical applications due to their biocompatibility, unique physicochemical properties, and cost-effective mass production. In addition, recent advances in nano-engineering technologies enable the generation of ZnO nanocomposites with unique three-dimensional structures and surface characteristics that are optimally designed for in vivo applications. Here, we review recent advances in the application of diverse ZnO nanocomposites, with an especial focus on their development as vaccine adjuvant and cancer immunotherapeutics, as well as their intrinsic properties interacting with the immune system and potential toxic effect in vivo. Finally, we summarize promising proof-of-concept applications as prophylactic and therapeutic vaccines against infections and cancers. Understanding the nano-bio interfaces between ZnO-based nanocomposites and the immune system, together with bio-effective design of the nanomaterial using nano-architectonic technology, may open new avenues in expanding the biomedical application of ZnO nanocomposites as a novel vaccine platform.

KW - Cancer

KW - Immune cells

KW - Immunotherapy

KW - Toxicity

KW - Vaccine

KW - ZnO nanocomposite

UR - http://www.scopus.com/inward/record.url?scp=85073795621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073795621&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics11100493

DO - 10.3390/pharmaceutics11100493

M3 - Review article

AN - SCOPUS:85073795621

VL - 11

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 10

M1 - 493

ER -